𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of combination therapy with 5′-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci

✍ Scribed by Wasaburo Koizumi; Minoru Kurihara; Tadashi Sasai; Shigeaki Yoshida; Kimitomo Morise; Akimichi Imamura; Shugo Akazawa; Takashi Betsuyaku; Shunji Ohkubo; Hiroshi Takahashi; Toshikazu Akiya; Tsutomu Hamada; Atsushi Kiyohashi

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
513 KB
Volume
72
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

Background. 5'-Deoxy-5-fluorouridine (5'-DFUR, doxifluridine) is a recently developed prodrug of oral From the Japan Gastric Cancer Study Group,

📜 SIMILAR VOLUMES

A phase ii study of the combination of e
A phase ii study of the combination of etoposide and cisplatin in the therapy of advanced gastric cancer
✍ Thomas E. Elliott; Charles G. Moertel; Harry S. Wieand; Richard G. Hahn; James B 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB 👁 2 views

Forty-eight patients with advanced gastric cancer and measurable areas of malignant disease were treated with etoposide (130 mg/mz/day X 3 days) plus cisplatin (45 mg/mzday on days 2 and 3). Both drugs were given by constant intravenous infusion and repeated every 4 weeks. Common toxic reactions inc

Phase II study of a modified combination
Phase II study of a modified combination of etoposide, doxorubicin, and cisplatin for patients with advanced gastric cancer
✍ Içli, Fikri; Karaoguz, Handan; Akbulut, Hakan; Dinçol, Dilek; Demirkazik, Ahmet; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

## Background: Based on the promising results of eap (etoposide, doxorubicin, and cisplatin) combination, a phase ii study of modified eap combination was performed in patients with advanced gastric cancer to evaluate the response, toxicity, and survival. ## Method: Fifty-two consecutive patients

Phase II study of 5-fluorouracil and fol
Phase II study of 5-fluorouracil and folinic acid in the treatment of patients with advanced gastric cancer: A Southwest Oncology Group study
✍ Giuseppe Colucci 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 3 views

n the article published in Cancer entitled "Phase I1 study of 5-fluoro-I uracil and folinic acid in the treatment of patients with advanced gastric cancer. A Southwest Oncology Group Study,"' the authors erroneously quoted the results of our study and we request a correction. In the results of our

Treatment of patients with advanced gast
Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen : Two parallel randomized phase II studies
✍ Carlo Barone; Domenico C. Corsi; Carmelo Pozzo; Alessandra Cassano; Tecla Fontan 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

370 mg/m 2 , on Days 1-5 and 36 others in Study B received epirubicin, 30 mg/m 2 , cina Interna e Geriatria, Universita `Cattolica del on Days 1 and 5; etoposide, 100 mg/m 2 , on Days 1, 3, and 5; cisplatin, 30 mg/m 2 , S. Cuore, Rome, Italy. on Days 2 and 4; and lonidamine, 150 mg/day. ## RESULTS